These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7297821)

  • 1. [Chronic hepatitis with elevated level of endoplasmic anti-reticulum antibodies: alpha-methyldopa or tienilic acid?].
    Beaugrand M; Gavillon C; Ferrier JP
    Gastroenterol Clin Biol; 1981; 5(8-9):819-20. PubMed ID: 7297821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute hepatitis due to tienilic acid].
    Joly JP; Elfil I; Capron JP
    Gastroenterol Clin Biol; 1981; 5(6-7):691-2. PubMed ID: 7250620
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fulminating hepatitis caused by tienilic acid].
    Lechevalier L; Lebrec D; Lam X; Chousterman M
    Gastroenterol Clin Biol; 1987 Mar; 11(3):262-3. PubMed ID: 3582880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatitis during treatment with tienilic acid (author's transl)].
    Bousquet O; Saigot T; Bernard P; Gerbal JL; Sarrazin A
    Therapie; 1980; 35(2):205-8. PubMed ID: 7414529
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cholestatic hepatitis with tienilic acid].
    Schumacher R; Lobeck H
    Med Welt; 1981 Mar; 32(12):402-3. PubMed ID: 7219153
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytolytic hepatitis, role of tienilic acid].
    Groussin P; Chavanne D; Renard JP; Medelsi M; Arbeille-Brassard B; Royere D
    Med Chir Dig; 1979; 8(5):463-5. PubMed ID: 534028
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)].
    Pariente EA; André C; Zafrani ES; Métreau JM; Dhumeaux D; Berthelot P
    Gastroenterol Clin Biol; 1981 May; 5(5):567-71. PubMed ID: 7250606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases].
    Lafay JP; Poupon R; Legendre C; Homberg JC; Darnis F
    Gastroenterol Clin Biol; 1983 May; 7(5):523-8. PubMed ID: 6873565
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatotoxicity due to tienilic acid].
    Bernuau J; Mallet L; Benhamou JP
    Gastroenterol Clin Biol; 1981; 5(6-7):692-3. PubMed ID: 7250621
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatic necrosis secondary to tienilic acid therapy (author's transl)].
    Mechali D; Marche C; Metayer J; Saimot G; Matheron S; Rozenbaum W; Coulaud JP
    Therapie; 1980; 35(2):197-203. PubMed ID: 7414528
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tienilic acid-induced hepatitis associated with liver/kidney microsomal antibody (author's transl)].
    Poupon R; Homberg JC; Abuaf N; Petit J; Bodin F; Darnis F
    Nouv Presse Med; 1980 Jun; 9(27):1881-4. PubMed ID: 7402892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tienilic acid as a likely cause of "auto immune" active hepatitis (author's transl)].
    Eugène C; Patriarche C; Bergue A; Quevauvilliers J
    Nouv Presse Med; 1980 Jun; 9(27):1885-7. PubMed ID: 6157146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.
    Homberg JC; Andre C; Abuaf N
    Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ticrynafen recalled.
    FDA Drug Bull; 1980 Feb; 10(1):3-4. PubMed ID: 7358240
    [No Abstract]   [Full Text] [Related]  

  • 15. [High levels of endoplasmic reticulum antibody titer in a case of alpha-methyldopa-induced chronic active hepatitis (author's transl)].
    Beaugrand M; Gavillon C; Ferrier JP
    Gastroenterol Clin Biol; 1980 Mar; 4(3):219-21. PubMed ID: 7380145
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatotoxicity associated with ticrynafen--a uricosuric diuretic.
    Manier JW; Chang WW; Kirchner JP; Beltaos E
    Am J Gastroenterol; 1982 Jun; 77(6):401-4. PubMed ID: 7091125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms in tienilic acid associated hepatotoxicity.
    Neuberger J; Williams R
    Gut; 1989 Apr; 30(4):515-9. PubMed ID: 2714684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction by drugs of hepatitis and autoantibodies to cell organelles: significance and interpretation.
    Mackay IR
    Hepatology; 1985; 5(5):904-6. PubMed ID: 4029900
    [No Abstract]   [Full Text] [Related]  

  • 19. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
    Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [For instance Selacryn].
    Bauch W
    Med Welt; 1980 Feb; 31(7):III. PubMed ID: 7366404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.